Tenax Therapeutics Inc. (NASDAQ: TENX)
$3.37
+0.0050 ( +0.15% ) 5.6K
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
Market Data
Open
$3.37
Previous close
$3.36
Volume
5.6K
Market cap
$6.57M
Day range
$3.21 - $3.42
52 week range
$2.77 - $61.20
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 20 | Feb 20, 2024 |
8-k | 8K-related | 23 | Feb 12, 2024 |
8-k | 8K-related | 18 | Feb 08, 2024 |
8-k | 8K-related | 18 | Feb 06, 2024 |
8-k | 8K-related | 14 | Jan 19, 2024 |
8-k | 8K-related | 14 | Jan 12, 2024 |
3 | Insider transactions | 2 | Jan 12, 2024 |
8-k | 8K-related | 17 | Jan 05, 2024 |
8-k | 8K-related | 14 | Dec 01, 2023 |
10-q | Quarterly Reports | 49 | Nov 13, 2023 |